摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氟-3-甲氧基苯酚 | 447462-87-5

中文名称
2-氟-3-甲氧基苯酚
中文别名
——
英文名称
2-fluoro-3-methoxyphenol
英文别名
——
2-氟-3-甲氧基苯酚化学式
CAS
447462-87-5
化学式
C7H7FO2
mdl
MFCD11110186
分子量
142.13
InChiKey
HRZRWOBHACTFLF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    222.0±20.0 °C(Predicted)
  • 密度:
    1.224±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2909500000
  • 包装等级:
    III
  • 危险类别:
    8
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P302+P352,P304+P340,P305+P351+P338,P310,P330,P332+P313,P362,P403+P233,P405,P501
  • 危险品运输编号:
    1759
  • 危险性描述:
    H302,H315,H318,H335

SDS

SDS:bf82cb289a2c57b8e1e8cf282d5d6657
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Fluoro-3-methoxyphenol
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Fluoro-3-methoxyphenol
CAS number: 447462-87-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H7FO2
Molecular weight: 142.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-氟-3-甲氧基苯酚三溴化硼 作用下, 以 二氯甲烷 为溶剂, 以93%的产率得到2-氟-1,3-苯二酚
    参考文献:
    名称:
    [EN] 3-SUBSTITUTED-1H-INDOLE, 3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
    [FR] COMPOSÉS 1H-INDOLE SUBSTITUÉ EN POSITION 3, 1H-PYRROLO[2,3-B]PYRIDINE SUBSTITUÉE EN POSITION 3 ET 1H-PYRROLO[3,2-B]PYRIDINE SUBSTITUÉE EN POSITION 3, LEUR UTILISATION COMME MTOR KINASE ET INHIBITEURS DE LA PI3 KINASE, ET LEURS SYNTHÈSES
    摘要:
    这项发明涉及Formula (I)的3-取代-1H-吲哚、3-取代-1H-吡咯并[2,3-b]吡啶和3-取代-1H-吡咯并[3,2-b]吡啶化合物,或其药学上可接受的盐,其中组成变量如本文所定义,包括这些化合物的组合物,以及制备和使用这些化合物的方法。
    公开号:
    WO2010030727A1
  • 作为产物:
    描述:
    2-氟-3-甲氧基苯硼酸三乙胺 作用下, 以 乙腈 为溶剂, 反应 36.0h, 以72%的产率得到2-氟-3-甲氧基苯酚
    参考文献:
    名称:
    聚合物支持的曙红Y作为可重复使用的光催化剂,用于可见光介导的有机转化
    摘要:
    已经开发了用于可见光介导的氧化反应的新型聚合物负载的可回收光催化剂。将有机染料曙红Y装载在可商购的大孔Amberlite IRA 900氯化物树脂上,并用作光催化剂,用于在敞开的大气中将可见光介导的硫醚氧化为亚砜和将苯基硼酸氧化为苯酚。氧化过程中对各种官能团的耐受性良好。该催化剂可循环使用六个周期,而效率没有明显损失。此外,已证明将克级的硫化物氧化为亚砜可证明该方法的商业可行性。
    DOI:
    10.1039/c9nj04064a
点击查看最新优质反应信息

文献信息

  • [EN] TRICYCLIC INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND USES THEREOF<br/>[FR] INHIBITEURS TRICYCLIQUES DE L'INTERACTION PROTÉINE-PROTÉINE DU DOMAINE BTB DE BCL6 ET UTILISATIONS ASSOCIÉES
    申请人:ONTARIO INSTITUTE FOR CANCER RES OICR
    公开号:WO2019119145A1
    公开(公告)日:2019-06-27
    The present application relates to compounds of Formula (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.
    本申请涉及式(I)的化合物或其药用可接受的盐、溶剂化合物和/或前药,包括含有这些化合物或其药用可接受的盐、溶剂化合物和/或前药的组合物,以及在治疗可通过抑制与BCL6 BTB的相互作用可治疗的疾病、紊乱或状况中的各种用途,如癌症。
  • PYRROLIDINONE GLUCOKINASE ACTIVATORS
    申请人:Berthel Steven Joseph
    公开号:US20090264445A1
    公开(公告)日:2009-10-22
    Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
    提供的化合物为公式(I): 以及药学上可接受的盐,其中取代基如说明书中所披露。这些化合物以及包含它们的药物组合物,可用于治疗代谢性疾病和障碍,例如,2型糖尿病。
  • 一种具有含氮桥环、螺环或并环结构的化合物 及其用途
    申请人:成都海博为药业有限公司
    公开号:CN111471048B
    公开(公告)日:2021-06-15
    本发明公开了一种具有含氮桥环、螺环或并环结构的化合物及其用途,该类化合物对蛋白质激酶活性具有明显的抑制作用,可作为BTK抑制剂,用于制备治疗由BTK介导的疾病的药物,所述由BTK介导的疾病包括但不限于自身免疫性疾病、恶性肿瘤等,具有广阔的应用前景。
  • [EN] HETEROCYCLYL PYRIDAZINE AS FUNGICIDAL COMPOUNDS<br/>[FR] HÉTÉROCYCLYL-PYRIDAZINE UTILISÉE EN TANT QUE COMPOSÉS FONGICIDES
    申请人:BAYER AG
    公开号:WO2020127780A1
    公开(公告)日:2020-06-25
    The present disclosure relates to heterocyclyl pyridazine compounds, processes and intermediates for their preparation as well as the uses thereof for controlling phytopathogenic microorganisms, such as phytopathogenic fungi.
    本公开涉及杂环吡啶嘧啶类化合物,它们的制备过程和中间体,以及用途,用于控制植物病原微生物,如植物病原真菌。
  • 3-SUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINE AND 3-SUBSTITUTED-1H-PYRROLO[3,2-B]PYRIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESES
    申请人:Tsou Hwei-Ru
    公开号:US20090298820A1
    公开(公告)日:2009-12-03
    The invention relates to 3-substituted-1H-pyrrolo[2,3-b]pyridine, and 3-substituted-1H-pyrrolo[3,2-b]pyridine compounds of the Formula 1: or a pharmaceutically acceptable salt thereof, wherein the constituent variables are as defined herein, compositions comprising the compounds, and methods for making and using the compounds.
    该发明涉及Formula 1中的3-取代-1H-吡咯[2,3-b]吡啶和3-取代-1H-吡咯[3,2-b]吡啶化合物,或其药学上可接受的盐,其中各组成变量如本文所定义,包括含有这些化合物的组合物,以及制备和使用这些化合物的方法。
查看更多